This inventor holds 1 USPTO granted patent. Top assignee: Nicox S.a.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Daniela Miglietta: Innovator in Muscular Dystrophy Treatment
Introduction
Daniela Miglietta is a prominent inventor based in Monza, Italy. She has made significant contributions to the field of medical research, particularly in the treatment of muscular dystrophies. Her innovative approach focuses on the use of nitric oxide releasing compounds to address these challenging conditions.
Latest Patents
Miglietta holds a patent for the "Use of nitrooxyderivative of drug for the treatment of muscular dystrophies." This invention relates to the application of nitric oxide releasing compounds for retarding or reversing muscular dystrophies, including Duchenne and Becker dystrophies. She has 1 patent to her name, showcasing her commitment to advancing medical science.
Career Highlights
Currently, Daniela Miglietta is associated with Nicox S.a., a company dedicated to developing innovative therapeutic solutions. Her work at Nicox S.a. emphasizes her dedication to improving the lives of individuals affected by muscular dystrophies.
Collaborations
Miglietta has collaborated with esteemed colleagues in her field, including Emilio Clementi and Giulio Cossu. These partnerships highlight her commitment to teamwork and the sharing of knowledge in the pursuit of medical advancements.
Conclusion
Daniela Miglietta is a trailblazer in the field of muscular dystrophy treatment, with her innovative patent and collaborative spirit. Her work continues to inspire and pave the way for future advancements in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile